<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fischer LE</submitter><funding>NIDDK NIH HHS</funding><funding>NCRR NIH HHS</funding><pagination>1787-1798</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9944569</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Postbariatric hypoglycemia (PBH) can be a devastating complication for which current therapies are often incompletely effective. More information is needed regarding frequency, incidence, and risk factors for PBH.&lt;h4>Objectives&lt;/h4>To examine hypoglycemia symptoms following Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB) and baseline and in-study risk factors.&lt;h4>Setting&lt;/h4>Multicenter, at 10 US hospitals in 6 geographically diverse clinical centers.&lt;h4&gt;Methods&lt;/h4>A prospective, longitudinal cohort study of adults undergoing RYGB or LAGB as part of clinical care between 2006 and 2009 were recruited and followed until January 31, 2015, with baseline and annual postoperative research assessments. We analyzed baseline prevalence and post</pubmed_abstract><journal>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery</journal><pubmed_title>Postbariatric hypoglycemia: symptom patterns and associated risk factors in the Longitudinal Assessment of Bariatric Surgery study.</pubmed_title><pmcid>PMC9944569</pmcid><funding_grant_id>U01 DK066667</funding_grant_id><funding_grant_id>U01 DK066557</funding_grant_id><funding_grant_id>U01 DK066568</funding_grant_id><funding_grant_id>U01 DK066526</funding_grant_id><funding_grant_id>R01 DK121995</funding_grant_id><funding_grant_id>U01 DK114156</funding_grant_id><funding_grant_id>R01 DK106193</funding_grant_id><funding_grant_id>U01 DK066585</funding_grant_id><funding_grant_id>U01 DK066555</funding_grant_id><funding_grant_id>UL1 RR024996</funding_grant_id><funding_grant_id>R01 DK103842</funding_grant_id><funding_grant_id>U01 DK066471</funding_grant_id><funding_grant_id>P30 DK036836</funding_grant_id><funding_grant_id>M01 RR000037</funding_grant_id><funding_grant_id>UL1 RR024153</funding_grant_id><pubmed_authors>McCloskey CA</pubmed_authors><pubmed_authors>Averbach F</pubmed_authors><pubmed_authors>Greene S</pubmed_authors><pubmed_authors>Cunningham E</pubmed_authors><pubmed_authors>Courcoulas AP</pubmed_authors><pubmed_authors>Fischer LE</pubmed_authors><pubmed_authors>Patterson E</pubmed_authors><pubmed_authors>King WC</pubmed_authors><pubmed_authors>Barker J</pubmed_authors><pubmed_authors>VanDerWerff L</pubmed_authors><pubmed_authors>Blissell R</pubmed_authors><pubmed_authors>Deveney C</pubmed_authors><pubmed_authors>Lancaster K</pubmed_authors><pubmed_authors>Monson T</pubmed_authors><pubmed_authors>Moonka R</pubmed_authors><pubmed_authors>Flum DR</pubmed_authors><pubmed_authors>Wahed A</pubmed_authors><pubmed_authors>Yanovski SZ</pubmed_authors><pubmed_authors>Berk PD</pubmed_authors><pubmed_authors>Miller MJ</pubmed_authors><pubmed_authors>Ebel F</pubmed_authors><pubmed_authors>Howell M</pubmed_authors><pubmed_authors>Strain G</pubmed_authors><pubmed_authors>Marcus M</pubmed_authors><pubmed_authors>Ng D</pubmed_authors><pubmed_authors>Daud A</pubmed_authors><pubmed_authors>Mercurio R</pubmed_authors><pubmed_authors>Thirlby R</pubmed_authors><pubmed_authors>Patti ME</pubmed_authors><pubmed_authors>Elder K</pubmed_authors><pubmed_authors>Hunter J</pubmed_authors><pubmed_authors>Sorenson C</pubmed_authors><pubmed_authors>Bessler M</pubmed_authors><pubmed_authors>Ball M</pubmed_authors><pubmed_authors>Wolfe BM</pubmed_authors><pubmed_authors>Schrope B</pubmed_authors><pubmed_authors>Dellinger EP</pubmed_authors><pubmed_authors>Kalarchian M</pubmed_authors><pubmed_authors>Ramanathan R</pubmed_authors><pubmed_authors>Cooley MM</pubmed_authors><pubmed_authors>LABS Investigators</pubmed_authors><pubmed_authors>Garcia L</pubmed_authors><pubmed_authors>Bowden R</pubmed_authors><pubmed_authors>Dakin G</pubmed_authors><pubmed_authors>Pender J</pubmed_authors><pubmed_authors>Kwiatkowski J</pubmed_authors><pubmed_authors>Turo A</pubmed_authors><pubmed_authors>Gourash W</pubmed_authors><pubmed_authors>Purnell J</pubmed_authors><pubmed_authors>Dohm L</pubmed_authors><pubmed_authors>Pories W</pubmed_authors><pubmed_authors>Gagner M</pubmed_authors><pubmed_authors>Miles CW</pubmed_authors><pubmed_authors>Cassady C</pubmed_authors><pubmed_authors>Stewart SD</pubmed_authors><pubmed_authors>Pories WJ</pubmed_authors><pubmed_authors>O'Rourke R</pubmed_authors><pubmed_authors>Khandelwal S</pubmed_authors><pubmed_authors>Horlick M</pubmed_authors><pubmed_authors>Mwelu J</pubmed_authors><pubmed_authors>Belle SH</pubmed_authors><pubmed_authors>Hsieh J</pubmed_authors><pubmed_authors>Cundiff B</pubmed_authors><pubmed_authors>Staten MA</pubmed_authors><pubmed_authors>Chang L</pubmed_authors><pubmed_authors>Coburn E</pubmed_authors><pubmed_authors>Raum W</pubmed_authors><pubmed_authors>Shirley E</pubmed_authors><pubmed_authors>Capasso M</pubmed_authors><pubmed_authors>Lovaas E</pubmed_authors><pubmed_authors>Elman MR</pubmed_authors><pubmed_authors>Purnell JQ</pubmed_authors><pubmed_authors>Moher E</pubmed_authors><pubmed_authors>Ude A</pubmed_authors><pubmed_authors>Kleiner DE</pubmed_authors><pubmed_authors>Martin D</pubmed_authors><pubmed_authors>Pomp A</pubmed_authors><pubmed_authors>Costa R</pubmed_authors><pubmed_authors>Chapman W</pubmed_authors><pubmed_authors>Lobdell H</pubmed_authors><pubmed_authors>Mitchell JE</pubmed_authors><pubmed_authors>Honohan J</pubmed_authors><pubmed_authors>Fino N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Postbariatric hypoglycemia: symptom patterns and associated risk factors in the Longitudinal Assessment of Bariatric Surgery study.</name><description>&lt;h4>Background&lt;/h4>Postbariatric hypoglycemia (PBH) can be a devastating complication for which current therapies are often incompletely effective. More information is needed regarding frequency, incidence, and risk factors for PBH.&lt;h4>Objectives&lt;/h4>To examine hypoglycemia symptoms following Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB) and baseline and in-study risk factors.&lt;h4>Setting&lt;/h4>Multicenter, at 10 US hospitals in 6 geographically diverse clinical centers.&lt;h4&gt;Methods&lt;/h4>A prospective, longitudinal cohort study of adults undergoing RYGB or LAGB as part of clinical care between 2006 and 2009 were recruited and followed until January 31, 2015, with baseline and annual postoperative research assessments. We analyzed baseline prevalence and post</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2026-05-29T09:03:15.895Z</modification><creation>2024-11-20T02:15:47.69Z</creation></dates><accession>S-EPMC9944569</accession><cross_references><pubmed>34294589</pubmed><doi>10.1016/j.soard.2021.04.021</doi></cross_references></HashMap>